Anna Mondino
Overview
Explore the profile of Anna Mondino including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
82
Citations
2091
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gasparri A, Pocaterra A, Colombo B, Taie G, Gnasso C, Gori A, et al.
J Exp Clin Cancer Res
. 2025 Mar;
44(1):88.
PMID: 40055773
Background: The αvβ6- and αvβ8-integrins, two cell-adhesion receptors upregulated in many solid tumors, can promote the activation of transforming growth factor-β (TGFβ), a potent immunosuppressive cytokine, by interacting with the...
2.
Belmonte B, Spada S, Allavena P, Benelli M, Bronte V, Casorati G, et al.
J Exp Clin Cancer Res
. 2025 Feb;
44(1):57.
PMID: 39966867
From 17 to 19th October 2024, the XXI Italian Network for Bio-Immunotherapy of Tumors Meeting (NIBIT) took place in Palermo, in the marvelous historical location of Teatro Politeama, under the...
3.
Pocaterra A, Citro A, Gnasso C, Canu T, Tosi A, Rosato A, et al.
Methods Cell Biol
. 2024 Nov;
190:133-150.
PMID: 39515877
No abstract available.
4.
Rospo G, Chila R, Matafora V, Basso V, Lamba S, Bartolini A, et al.
Genome Med
. 2024 Jan;
16(1):15.
PMID: 38243308
Background: Immunotherapy based on checkpoint inhibitors is highly effective in mismatch repair deficient (MMRd) colorectal cancer (CRC). These tumors carry a high number of mutations, which are predicted to translate...
5.
Caronni N, La Terza F, Vittoria F, Barbiera G, Mezzanzanica L, Cuzzola V, et al.
Nature
. 2023 Nov;
623(7986):415-422.
PMID: 37914939
Pancreatic ductal adenocarcinoma (PDAC) is a lethal disease with high resistance to therapies. Inflammatory and immunomodulatory signals co-exist in the pancreatic tumour microenvironment, leading to dysregulated repair and cytotoxic responses....
6.
Gatti L, Chirizzi C, Rotta G, Milesi P, Sancho-Albero M, Sebastian V, et al.
Nanoscale Adv
. 2023 Jul;
5(14):3749-3760.
PMID: 37441254
cell tracking by non-invasive imaging technologies is needed to accelerate the clinical translation of innovative cell-based therapies. In this regard, F-MRI has recently gained increased attention for unbiased localization of...
7.
Gregucci F, Spada S, Barcellos-Hoff M, Bhardwaj N, Chan Wah Hak C, Fiorentino A, et al.
Oncoimmunology
. 2023 Jun;
12(1):2222560.
PMID: 37363104
Focal radiation therapy (RT) has attracted considerable attention as a combinatorial partner for immunotherapy (IT), largely reflecting a well-defined, predictable safety profile and at least some potential for immunostimulation. However,...
8.
9.
Perucho L, Icardi L, Di Simone E, Basso V, Agresti A, Vilas Zornoza A, et al.
EMBO Rep
. 2023 Mar;
24(5):e55326.
PMID: 36929576
The Sin3 transcriptional regulator homolog A (Sin3A) is the core member of a multiprotein chromatin-modifying complex. Its inactivation at the CD4/CD8 double-negative stage halts further thymocyte development. Among various functions,...
10.
Gritti I, Basso V, Rinchai D, Corigliano F, Pivetti S, Gaviraghi M, et al.
EMBO J
. 2022 Oct;
41(22):e108040.
PMID: 36215697
The ribonuclease DIS3 is one of the most frequently mutated genes in the hematological cancer multiple myeloma, yet the basis of its tumor suppressor function in this disease remains unclear....